Headlands Technologies LLC Natera, Inc. Transaction History

Headlands Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$85.28 - $112.6 $253,793 - $335,097	2,976 New	2,976 $322,000
Q4 2023 Feb 02, 2024	SELL	$37.55 - $62.64 $11,753 - $19,606	-313 Reduced 99.05%	3 $0
Q3 2023 Nov 09, 2023	BUY	$43.4 - $62.52 $13,714 - $19,756	316 New	316 $13,000
Q1 2023 May 01, 2023	BUY	$36.57 - $58.29 $73 - $116	2 New	2 $0

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.